Document is current
Any future updates will be listed below
-
Authors
Tronieri, Jena S. https://orcid.org/0000-0003-3587-4130
Wadden, Thomas A. https://orcid.org/0000-0002-0438-4609
Pearl, Rebecca L. https://orcid.org/0000-0002-1996-0082
Berkowitz, Robert I. https://orcid.org/0000-0002-5877-8195
Alamuddin, Naji
Chao, Ariana M. https://orcid.org/0000-0001-5633-8973
-
Funding
Funding for this research was provided by:
Eisai Korea
National Institute of Diabetes and Digestive and Kidney Diseases (K23DK116935)
National Heart, Lung, and Blood Institute (K23HL140176)
National Institute of Nursing Research (K23NR017209)
- License Information
-
More Information
Article History
First Online: 18 September 2020
Compliance with Ethical Standards
:
: JST and NA have served as consultants to Novo Nordisk. TAW reports serving on advisory boards for Novo Nordisk and WW (Weight Watchers). RIB serves as a consultant to Eisai Pharmaceutical, and AMC has consulted with Shire Pharmaceutical. The other authors declare no conflict of interest.
: This study was approved by Institutional Review Board at the University of Pennsylvania and was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All participants provided informed consent prior to their inclusion in the study.
